The synthesis of biocompatible nanoporous zeolitic imidazolate
framework-8 (ZIF-8) was performed in the presence of gum arabic (GA),
curcumin (CCM), and folic acid (FA) as a template for the biomineralization
process, a natural anticancer component, and a targeting agent, respectively.
The synthesis of ZIF-8-GA-CCM-FA was completed in a single step at
room temperature in aqueous media with a minimum amount of ethanol
at a linker/metal molar ratio of 10. FA was dissolved by the alkaline
medium produced by a 2-methyl imidazolium (HmIm) linker without using
any toxic organic solvent or additional conjugation agents. The FA-modified
carrier can target the folate receptors on Hela cells. To the best
of our knowledge, this is the first report about the one-pot encapsulation
of CCM and FA in a biocompatible ZIF-8-GA framework in a green solvent.
This method enables high CCM loading in the ZIF-8-GA framework structure
(ca. 90%) at a short time of 15 min. The effect of CCM concentration
was investigated on the size, morphology, and crystallinity of the
synthesized structures. The products were characterized with field
emission scanning electron microscopy, Brunauer–Emmett–Teller
surface area analysis, X-ray diffraction, Fourier transform infrared,
and UV–vis spectroscopy techniques. The release rate of CCM
from ZIF-8-GA-CCM-FA was studied at different pH values. In vitro
drug release of CCM was higher in the acidic medium (pH 5.5, 6.5)
compared to physiological pH (7.4). The cytotoxicity of ZIF-8-GA,
ZIF-8-GA-CCM, and ZIF-8-GA-CCM-FA structures was evaluated by the
standard 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay on the three cell lines (fibroblast (normal cell), Hela
(FR-positive), and A549 (FR-negative). These results suggested that
the ZIF-8-GA-CCM-FA framework can have a promising effect on the targeted
treatment of cancer cells.